“…Much more work needs to be done with regard to the optimal dosing of GBP in various surgical populations and this medication's efficacy at treating postoperative pain beyond the immediate 24 h or 48 h. Because many of the GBP trials published to this point have demonstrated a significant reduction in movementevoked pain (5,11,14,16,24,27,29), we hypothesized that continuing GBP into the rehabilitation period would lead to decreased pain during rehabilitation treatments and improved functional recovery (ie, a greater range of motion).…”